80
Participants
Start Date
March 29, 2022
Primary Completion Date
December 31, 2026
Study Completion Date
January 31, 2027
Active Comparator
QL block with 0.25% ropivacaine
Placebo Comparator
QL block with saline
RECRUITING
UCLA Medical Center, Santa Monica, Santa Monica
University of California, Los Angeles
OTHER